RNA Analysis/Transcriptomics Trends and Forecast
The future of the global RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets. The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.
A more than 150-page report is developed to help in your business decisions.
RNA Analysis/Transcriptomics by Segment
The study includes a forecast for the global RNA analysis/transcriptomics by product type, technology, application, end use, and region.
RNA Analysis/Transcriptomics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
- Consumables
- Instruments
- Software
- Services
RNA Analysis/Transcriptomics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- Real Time-PCR (qPCR)
- Microarray
- Sequencing
- Others
RNA Analysis/Transcriptomics Market by Application [Shipment Analysis by Value from 2018 to 2030]:
- Drug Discovery
- Diagnostics & Disease Profiling
- Others
RNA Analysis/Transcriptomics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Government Institutes & Academic Centers
- Pharmaceutical & Biotechnology
- Hospitals & Clinics
- Contract Research Organizations (CROs)
- Others
RNA Analysis/Transcriptomics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of RNA Analysis/Transcriptomics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA analysis/transcriptomics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA analysis/transcriptomics companies profiled in this report include-
- Agilent Technologies
- F. Hoffmann-La Roche
- Illumina
- QIAGEN
- Thermo Fisher Scientific
- Eurofins Scientific
- Merck KGaA
- Bio-Rad Laboratories
- Pacific Bioscience of California
- Affymetrix
RNA Analysis/Transcriptomics Market Insights
Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.
North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.
Features of the Global RNA Analysis/Transcriptomics Market
Market Size Estimates: RNA analysis/transcriptomics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: RNA analysis/transcriptomics market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).
Regional Analysis: RNA analysis/transcriptomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the RNA analysis/transcriptomics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA analysis/transcriptomics market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the RNA analysis/transcriptomics market size?
Answer: The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030.
Q2. What is the growth forecast for RNA analysis/transcriptomics market?
Answer: The global RNA analysis/transcriptomics market is expected to grow with a CAGR of 10.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the RNA analysis/transcriptomics market?
Answer: The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.
Q4. What are the major segments for RNA analysis/transcriptomics market?
Answer: The future of the RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets.
Q5. Who are the key RNA analysis/transcriptomics market companies?
Answer: Some of the key RNA analysis/transcriptomics companies are as follows:
- Agilent Technologies
- F. Hoffmann-La Roche
- Illumina
- QIAGEN
- Thermo Fisher Scientific
- Eurofins Scientific
- Merck KGaA
- Bio-Rad Laboratories
- Pacific Bioscience of California
- Affymetrix
Q6. Which RNA analysis/transcriptomics market segment will be the largest in future?
Answer: Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.
Q7. In RNA analysis/transcriptomics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the RNA analysis/transcriptomics market by product type (consumables, instruments, software, and services), technology (real time-pcr (qPCR), microarray, sequencing, and others), application (drug discovery, diagnostics & disease profiling, and others), end use (government institutes & academic centers, pharmaceutical & biotechnology, hospitals & clinics, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
